ArticleBMC medical informatics and decision making2025
AI-driven prognostics in pediatric bone marrow transplantation: a CAD approach with Bayesian and PSO optimization.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A lightweight ResNet50V2-ECA model for renal cell carcinoma grading: efficiency, calibration, and state-of-the-art performance.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone marrow transplantation (BMT) is a critical treatment for various hematological diseases in children, offering a potential cure and significantly improving patient outcomes. However, the complexity of matching donors and recipients and predicting post-transplant complications presents significant challenges. In this context, machine learning (ML) and artificial intelligence (AI) serve essential functions in enhancing the analytical processes associated with BMT. This study introduces a novel Computer-Aided Diagnosis (CAD) framework that analyzes critical factors such as genetic compatibility and human leukocyte antigen types for optimizing donor-recipient matches and increasing the success rates of allogeneic BMTs. The CAD framework employs Particle Swarm Optimization for efficient feature selection, seeking to determine the most significant features influencing classification accuracy. This is complemented by deploying diverse machine-learning models to guarantee strong and adaptable analytical capabilities. The Adaptive Tree of Parzen Estimators (TPE), a Bayesian optimization technique, is a key component of the proposed methodology. TPE is instrumental in navigating the complex hyperparameter space to optimize model performance, enhancing the overall effectiveness of the ML algorithms. Besides, the study investigates the impact of various scaling techniques on model performance, including L1 normalization and L2 normalization, ensuring that data preprocessing is optimized for the best possible outcomes. The Local Interpretable Model-Agnostic Explanations (LIME) framework is utilized to enhance model transparency and interpretability, bridging the gap between complex AI algorithms and clinical usability. This study uses a comprehensive dataset titled "Bone Marrow Transplant: Children, which is the analysis's foundation. The findings, validated by ANOVA and T-tests, reveal significant associations between several factors and survival status, highlighting the importance of Donorage, extcGvHD, PLTrecovery, and survival_time, among others. The optimal CAD framework employs a majority voting ensemble of seven finely-tuned machine learning algorithms, achieving remarkable performance metrics. The proposed CAD framework not only achieves high accuracy (98.07%), Balanced Accuracy (98.08%), precision (98.45%), recall (98.02%), specificity (98.14%), F1 score (98.23%), and Intersection over Union (96.53%) but also offers interpretable insights into the classification procedure, contributing significantly as a comprehensive tool for clinicians in the domain of childhood BMT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.